Physician

Raynor Christopher Casey, M.D.

According to 2025 Medicare claims, Raynor Casey, M.D. (NPI: 1821014440) practices ophthalmology in the Raleigh-Cary, NC market, with the plurality of this provider's patient population coming from Wake, NC. This provider's primary affiliated billing organization is RETINA ASSOCIATES, PLLC (NPI: 1760408397; TIN: 562043271) and primary practice location at 27607-7514.

Casey's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 478 traditional Medicare patients, billed 13,849 HCPCS/CPT codes, and received $2,519,363 in Medicare payments. The top billing code was J0177 (Injection, aflibercept hd, 1 mg). Part D data shows 106 prescription claims across 31 beneficiaries totaling $36,394 in drug costs, led by Bromfenac Sodium (Bromfenac Sodium). Open Payments data shows 22 records totaling $1,696. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $12,354 and ending at $36,394. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.3M$2.5M2015 Medicare payment: $2,161,866 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,877,538 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,838,655 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,953,186 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,937,099 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,177,389 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,042,360 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,979,328 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,947,205 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,519,363 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20155758,527$2,161,866
20165417,419$1,877,538
20175397,523$1,838,655
20185818,202$1,953,186
20196568,384$1,937,099
20206018,684$2,177,389
20215468,111$2,042,360
20225608,306$1,979,328
202353511,107$1,947,205
202447813,849$2,519,363

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$18K$36K2015 Drug cost: $12,354 (USD; Tot_Drug_Cst)2016 Drug cost: $8,385 (USD; Tot_Drug_Cst)2017 Drug cost: $8,901 (USD; Tot_Drug_Cst)2018 Drug cost: $7,093 (USD; Tot_Drug_Cst)2019 Drug cost: $8,175 (USD; Tot_Drug_Cst)2020 Drug cost: $10,893 (USD; Tot_Drug_Cst)2021 Drug cost: $9,097 (USD; Tot_Drug_Cst)2022 Drug cost: $15,543 (USD; Tot_Drug_Cst)2023 Drug cost: $5,957 (USD; Tot_Drug_Cst)2024 Drug cost: $36,394 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201571186$12,354
201651144$8,385
201743145$8,901
201841110$7,093
201945107$8,175
20204198$10,893
20213265$9,097
20223499$15,543
20232765$5,957
202431106$36,394

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0177Injection, aflibercept hd, 1 mg1284,424$264
67028Injection of drug into eye2051,015$96
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more375519$65
92134Imaging of retina226792$29
92250Photography of the retina440570$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Bromfenac SodiumBromfenac Sodium16379$2,137
Prednisolone AcetatePrednisolone Acetate21930$853
Diclofenac SodiumDiclofenac Sodium13470$120

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.22$1,696Astellas Pharma US Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Raynor Christopher Casey, M.D.?

Tedicare shows public-source Medicare data for Raynor Christopher Casey, M.D. (NPI 1821014440), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Raynor Christopher Casey, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Raynor Christopher Casey, M.D.?

Raynor Christopher Casey, M.D. is linked to RETINA ASSOCIATES, PLLC (billing NPI 1760408397) in the available physician profile data.

Does Raynor Christopher Casey, M.D. have Open Payments data?

Raynor Christopher Casey, M.D. has 22 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.